Histaminergic mechanisms in experimental convulsions

Area of Science:

• Neuroscience
• Pharmacology
• Convulsive Disorders

Background:

• Histamine (HA) plays a role in various physiological processes.
• Experimental models of seizures are crucial for understanding epilepsy.
• The role of histamine in seizure modulation requires further investigation.

Purpose of the Study:

• To investigate the effect of histamine agonists and antagonists on electroshock-induced seizures (MES) in mice and rats.
• To explore the potential role of histamine in regulating experimental convulsions.

Main Methods:

• Administration of histamine precursor (l-histidine) and histamine blockers (H1 and H2) in mice and rats.
• Induction of seizures using maximal electroshock (MES) stimulus.
• Assessment of seizure incidence and tonic hind limb extensor phase (THE).
• Evaluation of H1 blockers against seizures induced by other convulsants (pentylenetetrazole, INH, caffeine, strychnine).

Main Results:

• L-histidine exacerbated MES-induced seizures in mice.
• H1 blockers (pheniramine, promethazine) significantly reduced seizure incidence and THE in both mice and rats.
• H2 blocker (cimetidine) and atropine did not show protective effects against MES-induced seizures.
• H1 blockers were ineffective against seizures induced by pentylenetetrazole, INH, caffeine, or strychnine.

Conclusions:

• Histamine H1 receptors appear to play a role in modulating electroshock-induced seizures.
• Histaminergic pathways may be involved in the regulation of experimental convulsions.
• Further research is warranted to elucidate the precise mechanisms of histamine's influence on seizure activity.